Drug seeking behavior

American Journal of Drug and Alcohol Abuse

Volumn 30, Issue 3, 2004, Pages 551-575

  Vukmir, Rade B ^a  

^a Northwest 931 Montefiore Hospital   (United States)

Author keywords

Addiction; Analgesia; Drug abuse; Drug seeking, behavior; Narcotic; Pain control

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE; BUPRENORPHINE; CARBAMAZEPINE; CLONIDINE; CODEINE; GABAPENTIN; HYDROCODONE BITARTRATE PLUS PARACETAMOL; KETOROLAC; LOFEXIDINE; METHADONE; MEXILETINE; MORPHINE; NALTREXONE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; ORPHENADRINE CITRATE; OXYCODONE; PARACETAMOL; PENTAZOCINE; PERCOCET; PETHIDINE; PHENOTHIAZINE; SEROTONIN UPTAKE INHIBITOR; STEROID; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ANALGESIA; BEHAVIOR; CHRONIC PAIN; CHRONICITY; CLINICAL PROTOCOL; CLINICAL TRIAL; CONSTIPATION; CONVALESCENCE; CORTICOSTEROID THERAPY; DIAGNOSTIC PROCEDURE; DRUG ABUSE; DRUG COST; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG INDICATION; DRUG OVERDOSE; DRUG USE; DYSPEPSIA; EMERGENCY WARD; HEALTH CARE PERSONNEL; HUMAN; LAW; MEDICOLEGAL ASPECT; METHADONE TREATMENT; NAUSEA; NERVE STIMULATION; NEUROPATHIC PAIN; OPIATE ADDICTION; PAIN; PAIN ASSESSMENT; PATIENT COUNSELING; PATIENT EDUCATION; PERIPHERAL NERVE; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; QUALITY OF LIFE; RETROSPECTIVE STUDY; REVIEW; SEDATION; SIDE EFFECT; WITHDRAWAL SYNDROME;

ACUTE DISEASE; ANALGESICS, OPIOID; CHRONIC DISEASE; CLINICAL TRIALS; COMORBIDITY; HUMANS; MOTIVATION; OPIOID-RELATED DISORDERS; PAIN; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS; UNITED STATES;

EID: 7244254222     PISSN: 00952990     EISSN: None     Source Type: Journal    
DOI: 10.1081/ADA-200032294     Document Type: Review

References (59)

1. Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965; 150:971-979.
2. Merskey H, Bogduk N. Classification Chronic Pain. Seattle: International Association for the Study of Pain Press, 1994:210.
3. Loeser JD, Melzack R. Pain: an overview. Lancet 1999; 3:1607-1609.
4. Loeser JD. Perspective on pain. In: Turner P, ed. Procedings of the First World Congress on Clinical Pharmacology and Therapeutics. London: Macmillan, 1980:316-326.
5. Besson JM. The neurobiology of pain. Lancet 1999; 353:1610-1615.
6. Woessner J. A conceptual model of pain. Pract Pain Manag 2002:8-16.
7. Caudill MA. Managing Pain Before It Manages You. New York: The Guilford Press, 1995:207.
8. Diagnostic Criteria from DSM-IV™ , American Psychiatric Association. Washington, DC: Division of Publications and Marketing, 1994.
9. American Society of Anesthesiologists Task Force on Pain Management, Acute Pain Section. Practice guidelines for acute pain management in the perioperative setting. Anesthesiology 1995; 82:1071-1081.
10. Warfield CA, Kahn CH. Acute pain management. Anesthesiology 1995; 83:1090-1094.
11. American Pain Society. Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Plan. 4th ed. 1999.
12. Weiss SC, Emanuel LL, Fairelough DL, Emanuel EJ. Understanding the experience of pain in terminally ill patients. Lancet 2001; 357:1311-1315.
13. Desbiens NA, Wu AW, Alzola C, Mueller-Rizner N, et al. Pain during hospitalization is associated with continued pain six months later in survivors of serious illness. Am J Med 1997; 103:269-276.
14. Desbiens NA, Wu AW, Broste SK, Wenger NS, et al. Pain and satisfaction with pain control in seriously ill hospitalized adults: findings from the SUPPORT research investigations. Crit Care Med 1996; 24:1953-1961.
15. Freire AX, Afessa B, Cawley P, Phelps S, et al. Characteristics associated with analgesia ordering in the intensive care unit and relationships with outcome. Crit Care Med 2002; 30:2468-2472.
16. Elliott AM, Smith BH, Penny KI, Smith WC, et al. The epidemiology of chronic pain in the community. Lancet 1999; 354:1248-1252.
17. Moulin DE, Iezzi A, Smireh R, Sharpe WK, et al. Randomized trial of oral morphine for chronic non-cancer pain. Lancet 1996; 347:143-147.
18. Ytterberg SR, Mahowald ML, Woods SR. Codeine and oxycodone use in patients with chronic rheumatic disease pain. Arthritis Rheum 1998; 41:1603-1612.
19. Montanez A, et al. First steps in quality improvement: a pilot program for the management of acute sickle cell pain. J Clin Outcomes Manag 2002; 9:19.
20. American Society of Anesthesiologist Task Force on Pain Management, Chronic Pain Section. Practice guidelines for chronic pain management. Anesthesiology 1997; 86:995-1004.
21. Boisaubin EV. The assessment and treatment of pain in the emergency room. Clin J Pain 1989; 5:S19-S25.
22. Todd KH, Samaroo N, Hoffman JR. Ethnicity as a risk factor for inadequate emergency department analgesia. JAMA 1993; 280:1537-1539.
23. Todd KH, Deaton C, D'Adamo AP, Goe L. Ethnicity and analgesic practice. Ann Emerg Med 2000; 35:11-16.
24. Petrack EM, Christopher NC, Kriwinsky J. Pain management in the emergency department: patterns of analgesic utilization. Pediatrics 1997; 99:711-714.
25. Selbst SM, Clark M. Analgesic use in the emergency department. Ann Emerg Med 1990; 19:1010-1013.
26. Singer AJ, Richman PB, Kowalska A, Thode HC. Comparison of patient and practitioner assessments of pain from commonly performed emergency department procedures. Ann Emerg Med 1999; 33:652-658.
27. Fosnocht DE, Swanson ER, Bossart P. Patient expectations for pain medication delivery. Am J Emerg Med 2001; 19:399-402.
28. Vissers RJ. Drug seekers offer opportunity to practice humane medicine. In ACEP News, Post Assembly Edition. 2002.
29. Waldrop RD, Mandry C. Health professional perceptions of opioid dependence among patients with pain. Am J Emerg Med 1995; 13:529-531.
30. Graber MA, Gjerde C, Bergus G, Ely J. The use of unofficial "problem patient" files and inter institutional information transfer in emergency medicine in Iowa. Am J Emerg Med 1995; 13:509-511.
31. Egerton J. Watch out for these drug scams. Med Econ 2002; 81-84.
32. Lechnyr R, Holmes HH. Taxonomy of pain patient behavior. Pain Manage Sept/Oct 2002; 18-23.
33. Crane M. Treating pain: dammed if you don't? Med Econ Nov. 2001; 66-68.
34. Johnson LJ. If you suspect drug abuse. Med Econ Aug. 2002; 104.
35. Duncan AM. Diversion of prescription narcotics. PRN Patient Rx Newsletter. Infinity Risk Care 2002; 24.
36. Jacobson PL, Mann JD. Evolving role of the neurologist in the diagnosis and treatment of chronic noncancer pain. Mayo Clin Proc 2003; 78:80-84.
37. Scheduled Narcotics. DEA Office, 21 CFR 1308.
38. Robeznieks A. Prescription drug abuse deadlier than use of illegal drugs. Am Med News Dec. 2002; 17.
39. Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medica use and abuse of opioid analgesics. JAMA 2000; 283:1710-1714.
40. Laine C, Hauck WW, Gourevitch MN, Rothman J, et al. Regular outpatient medical drug abuse care and subsequent hospitalization of persons who use illicit drugs. JAMA 2001; 285:2355-2362.
41. Manfredini R, Gallerani M, Calo G, Pasin M, et al. Emergency admissions of opioid drug abusers for overdose: a chronobiological study of enhanced risk. Ann Emerg Med 1994; 24:615-618.
42. Silverstein JH, Silva DA, Iberti TJ. Opioid addiction in anesthesiology. Anesthesiology 1993; 79:354-375.
43. Parley WJ, Arnold WP. Unmasking addiction: chemical dependency in anesthesiology. In: Brochure Produced by Janssen Pharmaceutical. 1991.
44. Schmidt KA, Schlesinger MD. A reliable accounting system for controlled substances in the operating room. Anesthesiology 1993; 78:184-190.
45. Drake D, Dyer J, Holzheimer B. Controlling substance abuse. Nurs Manage June 1997; 40B-40F.
46. O'Brien CP, McLellan AT. Myths about the treatment of addiction. Lancet 1996; 347:237-240.
47. Seivewright NA, Greenwood J. What is important in drug misuse treatment? Lancet 1996; 347:373-376.
48. National Consensus Development Panel. Effective medical treatment of opiate addiction. JAMA 1998; 280:1936-1943.
49. Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. Lancet 1999; 353:221-226.
50. Weaver MF, Jarvis MA, Schnoll SH. Role of the primary care physician in problems of substance abuse. Arch Intern Med 1999; 159:913-924.
51. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
52. Weisner C, Mertens J, Parthasarathy S, Moore C, et al. Integrating primary medical care with addiction treatment. JAMA 2001; 286:1715-1723.
53. Fiellin DA, O'Connor PG, Chawarski M, Pakes JP, et al. Methadone maintenance in primary care. JAMA 2001; 286:1724-1731.
54. Safe Prescribing of Transdermal Fentanyl. Pittsburgh Regional Healthcare Initiative (PRHI), 2003.
55. Robeznieks A. Prosecutor seeks physicians' help in halting drug diversion. Am Med News 2002; 11:13.
56. Bolen.
57. Joranson DE, Gilson AM, Dahl JL, Haddox JD. Pain management, controlled substances, and state medical board policy: a decade of change. J Pain Symptom Manage 2002; 23:138-147.
58. Berridge V. Drug policy: should the law take a back seat? Lancet 1996; 347:305-310.
59. Federal initiatives change options for managing opioid dependence. Ann Intern Med 2002; 13:280-281.